Amwell announced strong Q3 2020 results, demonstrating significant growth in revenue, visits, and active providers. The company's platform is playing an increasingly important role in meeting the demand for telehealth infrastructure.
Total active providers increased 930% year-over-year, reaching approximately 62,000.
Total visits increased 450% year-over-year, totaling 1,414,000.
Revenue increased 80% year-over-year, reaching $62.6 million.
Announced new products including Amwell Now, Touchpoint Tablet software, and C500 telemedicine cart.
For 2020, Amwell expects revenue between $235 million and $239 million and Adjusted EBITDA between ($110) million and ($105) million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance